Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Anavex Life Sciences Corp. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 136 | 149 | +13 |
| Shares | 20.6M | 22.1M | +1.50M (+7.3%) |
| Value | $370.1M | $383.2M | +$13.2M (+3.6%) |
New holders (32)
Institutions that held Anavex Life Sciences Corp. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (19)
Institutions that held Anavex Life Sciences Corp. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Voloridge Investment Management, LLC | 150,710 | $2.71M |
| Kestra Private Wealth Services, LLC | 100,300 | $1.80M |
| Miracle Mile Advisors, LLC | 61,656 | $1.11M |
| ExodusPoint Capital Management, LP | 35,342 | $634.0K |
| Manufacturers Life Insurance Company, The | 31,809 | $571.0K |
| Old Mission Capital LLC | 30,366 | $545.0K |
| Gsa Capital Partners LLP | 30,301 | $544.0K |
| Ergoteles LLC | 28,600 | $513.0K |
| HAP Trading, LLC | 27,871 | $500.0K |
| Quantitative Investment Management, LLC | 21,436 | $384.0K |
| Alpine Global Management, LLC | 12,548 | $225.0K |
| Cahill Financial Advisors Inc | 3,500 | $63.0K |
| Cutler Group LP | 2,500 | $44.0K |
| Nisa Investment Advisors, LLC | 990 | $18.0K |
| North Star Investment Management Corp. | 1,000 | $18.0K |
| Meeder Asset Management Inc | 540 | $8.00K |
| Glen Eagle Advisors, LLC | 300 | $5.38K |
| Walleye Trading LLC | 142 | $3.00K |
| TD Private Client Wealth LLC | 33 | $592 |